T cell-derived IFNγ instructs ECM crosslinking by cardiac fibroblasts through LOXL3 in experimental cardiometabolic HFpEF
Ramona Emig, Zachary L. Robbe, Celina Kley, Sasha A. Smolgovsky, Abraham L. Bayer, Joshua G. Travers, Robert M. Blanton, Timothy A. McKinsey, Lauren Deems Black, Pilar Alcaide
This study identifies T cell-derived IFNγ as a driver of ECM stiffening in HFpEF via LOXL3 in cardiac fibroblasts, showing therapeutic potential for targeting this pathway.
Circulation Research · Oct 28, 2026Peer-reviewedPathology